Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.67
-0.07 (-0.65%)
At close: Mar 6, 2026, 4:00 PM EST
10.46
-0.21 (-1.97%)
After-hours: Mar 6, 2026, 7:39 PM EST
Phathom Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 175.11 | 55.25 | 0.68 | - | - | |
| Revenue Growth (YoY) | 216.93% | 8001.47% | - | - | - | |
| Cost of Revenue | 22.6 | 7.97 | 0.17 | - | - | |
| Gross Profit | 152.51 | 47.28 | 0.52 | - | - | |
| Selling, General & Admin | 279.72 | 290.66 | 117.93 | 101 | 62.74 | |
| Research & Development | 32.78 | 34.08 | 49.9 | 71.44 | 72.34 | |
| Operating Expenses | 312.5 | 324.75 | 167.83 | 172.44 | 135.08 | |
| Operating Income | -159.99 | -277.47 | -167.31 | -172.44 | -135.08 | |
| Interest Expense | -68.12 | -72.01 | -41.97 | -27.31 | -6.79 | |
| Interest & Investment Income | 7.04 | 15.16 | 7.88 | 2.13 | 0.04 | |
| Other Non Operating Income (Expenses) | -0.19 | -0.01 | -0.19 | -0.11 | -0.06 | |
| EBT Excluding Unusual Items | -221.25 | -334.33 | -201.59 | -197.72 | -141.88 | |
| Other Unusual Items | - | - | - | - | -2 | |
| Pretax Income | -221.25 | -334.33 | -201.59 | -197.72 | -143.88 | |
| Net Income | -221.25 | -334.33 | -201.59 | -197.72 | -143.88 | |
| Net Income to Common | -221.25 | -334.33 | -201.59 | -197.72 | -143.88 | |
| Shares Outstanding (Basic) | 73 | 63 | 51 | 39 | 37 | |
| Shares Outstanding (Diluted) | 73 | 63 | 51 | 39 | 37 | |
| Shares Change (YoY) | 15.42% | 23.18% | 31.11% | 5.72% | 11.36% | |
| EPS (Basic) | -3.03 | -5.29 | -3.93 | -5.05 | -3.89 | |
| EPS (Diluted) | -3.03 | -5.29 | -3.93 | -5.05 | -3.89 | |
| Free Cash Flow | -167 | -266.91 | -139.21 | -147.57 | -148.79 | |
| Free Cash Flow Per Share | -2.29 | -4.22 | -2.71 | -3.77 | -4.02 | |
| Gross Margin | 87.09% | 85.57% | 75.51% | - | - | |
| Operating Margin | -91.36% | -502.18% | -24532.55% | - | - | |
| Profit Margin | -126.35% | -605.09% | -29558.94% | - | - | |
| Free Cash Flow Margin | -95.37% | -483.07% | -20412.61% | - | - | |
| EBITDA | -159.35 | -276.67 | -166.74 | -171.82 | -134.56 | |
| EBITDA Margin | -91.00% | - | - | - | - | |
| D&A For EBITDA | 0.63 | 0.8 | 0.58 | 0.62 | 0.52 | |
| EBIT | -159.99 | -277.47 | -167.31 | -172.44 | -135.08 | |
| EBIT Margin | -91.36% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.